News & Investors
News
Lumicell Supports Stand Up To Cancer Dream Team for Early Detection of Gastric Cancer with Investigational Device and New Drug
Global Team Will Launch Gastric Cancer Prevention Clinical Trial. CAUTION – Investigational device and new drug. Limited by Federal (or United States) law to investigational use.
- Los Angeles
- January 8, 2026
Lumicell Highlights Growing Role of LumiSystem® as Commercial Expansion Accelerates, including Implementation at Nation’s Leading Cancer Center
Lumicell, Inc., a leader in fluorescence-guided imaging technologies for cancer detection, today highlighted the growing clinical relevance of LumiSystem®, the company’s real-time intraoperative imaging platform for breast-conserving surgery, as Lumicell
Lumicell Promotes Marnie Curbow as Chief Commercial Officer to Drive Next Phase of Growth
Lumicell Promotes Marnie Curbow as Chief Commercial Officer to Drive Next Phase of Growth Waltham, MA – Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection,
Lumicell Showcases Expanded Scientific and Clinical Engagement at ASBrS 2026 Annual Meeting
Seattle, WA — May 1, 2026 — Lumicell, a leader in intraoperative fluorescence imaging technology for breast cancer surgery, announced today its expanded presence at the American Society of Breast
Lumicell Featured on Health Uncensored with Dr. Drew to Discuss Advances in Breast Cancer Surgery
Waltham, MA — April 2026 — Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, announced today that it will be featured on Health Uncensored with
Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors
Newton, MA [February 4, 2026] — Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced the appointment of Cheryl R. Blanchard, Ph.D., to its
Lumicell Supports Stand Up To Cancer Dream Team for Early Detection of Gastric Cancer with Investigational Device and New Drug
Los Angeles, January 8, 2026 – Global Team Will Launch Gastric Cancer Prevention Clinical Trial. CAUTION – Investigational device and new drug. Limited by Federal (or United States) law to
Lumicell Announces Collaboration with Learn Look Locate to Empower Breast Cancer Patients through Lumpectomy Education
Newton, MA — December 18, 2025 — Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced a new collaboration with Learn Look Locate, a
Lumicell Announces Promising Feasibility Trial Findings Using Pegulicianine in Gastrointestinal Cancer Patients
Pioneering real-time detection of cancer brings promise to enabling a more complete resection in gastrointestinal cancer surgery Newton, MA – Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for
Lumicell Announces U.S. Launch and First Commercial Use of LumiSystem™, Pioneering Real-Time Detection of Residual Breast Cancer During Lumpectomy
LumiSystem is the first and only fluorescence-guided imaging technology for breast cancer detection, enabling a more complete resection Newton, MA – Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging
Events
San Antonio Breast Cancer Symposium®,
December 10-14, 2024
Henry B. Gonzalez Convention Center
Investors